Current radical mesothelioma treatments include chemotherapy, radiotherapy, surgery and experimental therapies and drugs. Research News reports the limited success of current treatment options for mesothelioma. News Mesothelioma research has shown that traditional treatments viz. Single or multiple drug chemotherapy has a response rate of 20%. Radiation, usually in combination with surgery or chemotherapy may be used in the treatment of pain and reduction of tumor mass, to facilitate breathing. However, irradiation can also cause serious side effects.

Efforts in the fight against mesothelioma, mesothelioma can take from ten to sixty years to develop after the inhalation of asbestos fibers breathe, but mesothelioma progresses rapidly. Radical surgery such as mesothelioma treatments have had limited success. Non-surgical treatments are tried pleural pneumonectomy (EPP) and pleurectomy. Treatment News reports that the EPP over 15% of patients die soon after surgery. EPP is the removal of the pleura, diaphragm, pericardium, part of the phrenic nerve and lung cancer struck throughout and is supported by chemotherapy or radiotherapy.

Pleurectomy treatments include the removal of the pleura, without all the lung. These treatments tend to be better in patients with the expansion of the lung, good for accumulating fluid. In combination with radiotherapy and pleurectomy in the treatment of the news that the survival rate at 22 months and up to 50% survival rate at 24 months was 41% of cases in a 27-group of patients with epithelial subtype of mesothelioma have. Surgical treatment of mesothelioma has not been shown to offer significant advantages over the limited non-surgical treatments.

Experimental drugs under review include treatments Onconase, lovastatin, and a combination of endostatin and angiostatin. Mesothelioma Research Foundation of America is funding research to cure mesothelioma. The USC Norris Comprehensive Cancer Center in Los Angeles, has completed Phase I clinical trials on a new medication they ensure mesothelioma. Phase II clinical trials take heed began in, Mesothelioma treatment, July 2004, opens interesting possibilities for the treatment of victims of mesothelioma.